Zhende Medical Co Ltd (603301) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.017x

Based on the latest financial reports, Zhende Medical Co Ltd (603301) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥101.93 Million ≈ $14.92 Million USD) by net assets (CN¥5.99 Billion ≈ $875.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Zhende Medical Co Ltd to measure how many days the company can operate on defensive assets alone.

Zhende Medical Co Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Zhende Medical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhende Medical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhende Medical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
G-bits Network Technology Xiamen Co Ltd
SHG:603444
0.134x
Dave Inc
NASDAQ:DAVE
0.403x
iRhythm Technologies Inc
NASDAQ:IRTC
-0.162x
Box Inc
NYSE:BOX
-0.369x
Hang Zhou Iron & Steel Co Ltd
SHG:600126
0.124x
Hualan Biological EngineeringInc
SHE:002007
0.024x
National Health Investors Inc
NYSE:NHI
0.035x
Viohalco S.A
BR:VIO
0.050x

Annual Cash Flow Conversion Efficiency for Zhende Medical Co Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Zhende Medical Co Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Zhende Medical Co Ltd (603301) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.96 Billion
≈ $872.47 Million
CN¥538.49 Million
≈ $78.80 Million
0.090x +15.48%
2024-12-31 CN¥5.90 Billion
≈ $862.83 Million
CN¥461.14 Million
≈ $67.48 Million
0.078x -3.05%
2023-12-31 CN¥5.60 Billion
≈ $820.10 Million
CN¥452.11 Million
≈ $66.16 Million
0.081x -62.73%
2022-12-31 CN¥5.76 Billion
≈ $842.43 Million
CN¥1.25 Billion
≈ $182.34 Million
0.216x +17.52%
2021-12-31 CN¥4.44 Billion
≈ $649.65 Million
CN¥817.63 Million
≈ $119.64 Million
0.184x -73.64%
2020-12-31 CN¥4.47 Billion
≈ $653.65 Million
CN¥3.12 Billion
≈ $456.68 Million
0.699x +394.48%
2019-12-31 CN¥1.40 Billion
≈ $204.82 Million
CN¥197.76 Million
≈ $28.94 Million
0.141x +684.88%
2018-12-31 CN¥1.12 Billion
≈ $164.57 Million
CN¥20.25 Million
≈ $2.96 Million
0.018x -94.47%
2017-12-31 CN¥560.19 Million
≈ $81.97 Million
CN¥182.34 Million
≈ $26.68 Million
0.326x +2.93%
2016-12-31 CN¥438.18 Million
≈ $64.12 Million
CN¥138.57 Million
≈ $20.28 Million
0.316x -41.84%
2015-12-31 CN¥262.45 Million
≈ $38.40 Million
CN¥142.70 Million
≈ $20.88 Million
0.544x -31.23%
2014-12-31 CN¥105.77 Million
≈ $15.48 Million
CN¥83.63 Million
≈ $12.24 Million
0.791x --

About Zhende Medical Co Ltd

SHG:603301 China Medical Instruments & Supplies
Market Cap
$3.44 Billion
CN¥23.48 Billion CNY
Market Cap Rank
#4630 Global
#812 in China
Share Price
CN¥89.00
Change (1 day)
+1.31%
52-Week Range
CN¥20.71 - CN¥100.22
All Time High
CN¥100.22
About

Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China and internationally. The company offers gauze swab, lap sponge, and fluff gauze swab; non-woven swab; PBT bandage, elastic bandage, crepe bandage, crochet bandage, selvedge bandage, under-cast padding, and fluff gauze roll; dressing set; first aid kit; cotton pa… Read more